ArticleBasic and clinical andrology2026
Divergent long-term trends in semen quality and reproductive hormones across the COVID-19 pandemic era in infertile men: an age-stratified retrospective study.
Article in Basic and clinical andrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundMale reproductive dysfunction has been reported during the acute phase of COVID-19. However, the long-term patterns in semen quality and hormonal parameters across the extended pandemic and post-pandemic periods, and whether these patterns differ by age, remain poorly characterized. This large-scale, retrospective study was conducted to delineate these trajectories in infertile men.
resultsAmong 90,125 records, normal sperm morphology showed a sustained deficit: the proportion of men with morphology ≥ 4% declined from 88.9% pre-pandemic to 55.1% in Post-Phase 2 (p < 0.001), with nearly half falling below the WHO clinical threshold (4%). Serum testosterone decreased modestly from 4.46 to 4.19 ng/mL (6.1% reduction; (p = 0.006) but remained above the hypogonadism threshold for most men. These alterations persisted two years into the post-pandemic period without returning to pre-pandemic baselines.
conclusionsThe COVID-19 pandemic was associated with persistent, clinically meaningful deficits in normal sperm morphology and a moderate, non-hypogonadal testosterone suppression, with distinct age-dependent patterns. These findings underscore the need for age-stratified reproductive health surveillance following major population-level stressors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.